{
    "Trade/Device Name(s)": [
        "BinaxNOW\u00ae G6PD Test",
        "BinaxNOW\u00ae G6PD",
        "Binax NOW\u00ae G6PD Test",
        "Binax NOW\u00ae G6PD",
        "NOW\u00ae G6PD Test",
        "NOW\u00ae G6PD"
    ],
    "Submitter Information": "Binax, Inc., d/b/a Inverness Medical",
    "510(k) Number": "K080003",
    "Predicate Device Reference 510(k) Number(s)": [
        "K933934"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JBF"
    ],
    "Summary Letter Date": "October 23, 2008",
    "Summary Letter Received Date": "October 15, 2008",
    "Submission Date": "December 31, 2007",
    "Regulation Number(s)": [
        "21 CFR 864.7360"
    ],
    "Regulation Name(s)": [
        "Glucose-6-Phosphate Dehydrogenase (Erythrocytic), Screening"
    ],
    "Analyte Class(es)": [
        "hematology"
    ],
    "Analyte(s)": [
        "Glucose-6-Phosphate Dehydrogenase (G6PD) enzyme activity"
    ],
    "Specimen Type(s)": [
        "Venous whole blood"
    ],
    "Specimen Container(s)": [
        "Heparin tube",
        "EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Lateral flow",
        "Enzyme chromatographic assay",
        "Visual colorimetric detection"
    ],
    "Methodologies": [
        "Qualitative enzyme activity assay",
        "Chromatographic lateral flow"
    ],
    "Submission Type(s)": [
        "Test",
        "Reagent",
        "Sample preparation",
        "Strip test",
        "Tube",
        "Container"
    ],
    "Document Summary": "FDA 510(k) summary for BinaxNOW G6PD lateral flow enzyme chromatographic test for qualitative detection of G6PD deficiency in whole blood.",
    "Indications for Use Summary": "Qualitative screening test for G6PD enzyme activity in human venous whole blood (heparin or EDTA), aiding identification of individuals with G6PD deficiency; deficient results require confirmation by quantitative assay.",
    "fda_folder": "Hematology"
}